Your Article Summary
See Latest ArticlesPopulation-based analysis of normal total PSA and percentage of free/total PSA values: results from screening cohort
Urology, 07/02/09
Capitanio U et al. - In a study to examine the distribution of total prostate-specific antigen (tPSA) and percentage of free/total PSA (%f/tPSA) values in pts undergoing prostate cancer (PCa) screening, the results can guide clinicians regarding population-based distribution of serum tPSA and %f/tPSA values. Those values can be used for counseling, as well as in the informed consent process before prostate biopsy.
Methods- Data from 4 consecutive annual PCa screening events held in Montreal, Canada were examined with respect to age, tPSA, and %f/tPSA in 3222 men.
- Median PSA level was 1.0 ng/mL and median %f/tPSA was 26%.
- Using the interquartile range around the median, the upper bound for tPSA was situated at 1.9 ng/mL and the lower bound for %f/tPSA was at 19%.
- The 90th percentile for median tPSA was 3.8, and the 10th percentile for median %f/tPSA was 14.
- PSA and %f/tPSA showed a relation with age.
- The 75th percentile for median tPSA level in the age category 40-49, 50-59, 60-69, and 70-79 yrs was 1.1, 1.4, 2.6, and 3.6 ng/mL, respectively.
- The 25th percentile for median %f/tPSA level in the age category 40-49, 50-59, 60-69, and 70-79 yrs was 19, 21, 18 and 19 ng/mL, respectively.
Related Articles
Prostatic specific antigen for prostate cancer detection
International Braz J Urol, 10/30/09
Relevance Score: 97%
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/16/09
Relevance Score: 92%
Relationship Between Prostate-specific Antigen and Hematocrit: Does Hemodilution Lead to Lower PSA Concentrations in Men With a Higher Body Mass Index
Urology, 10/28/09
Relevance Score: 89%
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Relevance Score: 89%
PSA at postoperative three months can predict biochemical recurrence in patients with pathological T3 prostate cancer following radical prostatectomy
International Journal of Urology, 10/15/09
Relevance Score: 89%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Smoking Status and Pain Level Among Head and Neck Cancer Patients
The Journal of Pain, 12/17/09
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
Men Presenting for Radical Prostatectomy on Preoperative Statin Therapy Have Reduced Serum Prostate Specific Antigen
The Journal of Urology, 12/17/09
Hypercalciuria is Related to Osmolar Excretion in Children With Nocturnal Enuresis
The Journal of Urology, 12/17/09